Synopsis
Synopsis
0
EU WC
0
KDMF
0
FDF
0
Australia
0
South Africa
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 4 Epitetracycline
2. 4-epitetracycline
3. Achromycin
4. Achromycin V
5. Hostacyclin
6. Sustamycin
7. Tetrabid
8. Tetracycline
9. Tetracycline Monohydrochloride
10. Topicycline
1. 64-75-5
2. Tetracycline Hcl
3. Achromycin Hydrochloride
4. Bristacycline
5. Sustamycin
6. Tetracycline.hcl
7. Cyclopar
8. Sumycin
9. Tetracycline (hydrochloride)
10. Achromycin V
11. Neocycline B
12. Vetquamycin 324
13. Achromycin
14. Supramycin
15. Telotrex
16. Nci-c55561
17. Nsc-757338
18. Quatrex
19. P6r62377kv
20. Dumocyclin
21. (4s,4as,5as,6s,12as)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide Hydrochloride
22. 64-75-5 (hcl)
23. Dsstox_cid_1321
24. Dsstox_rid_76081
25. Dsstox_gsid_21321
26. (4s,4as,5as,6s,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide Monohydrochloride
27. Hostacycline
28. Mephacyclin
29. Quadracycline
30. Remicyclin
31. Stilciclina
32. Tetrabakat
33. Tetracompren
34. Tetralution
35. Tetramavan
36. Topicycline
37. Triphacyclin
38. Actisite
39. Artomycin
40. Diacycine
41. Partrex
42. Piracaps
43. Ricycline
44. Subamycin
45. Tefilin
46. Tetrabid
47. Tetrablet
48. Tetracaps
49. Tetrakap
50. Tetramed
51. Tetrosol
52. Paltet
53. Qidtet
54. Retet
55. Teline
56. Unicin
57. Tetra-wedel
58. Neocyclin B
59. Ro-cycline
60. Polyotic Ointment
61. Tetrasure
62. Tet-cy
63. Tetra-d
64. Vetquamycin-324
65. Cancycline-250
66. (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
67. 2-naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, Monohydrochloride,(4s,4as,5as,6s,12as)-
68. Cefracycline Tablets
69. Tetracycline Chloride
70. Panmycin Hydrochloride
71. Sentry Av Ornacycline
72. T-250 Capsules
73. Tetracyn Hydrochloride
74. Tetraciclina Cloridrato
75. Ala Tet
76. Polycycline Hydrochloride
77. Chlorowodorku Tetracykliny
78. Mfcd00078142
79. Chlorhydrate De Tetracycline
80. Unii-p6r62377kv
81. Ccris 2351
82. Sr-01000000212
83. Sr-05000001723
84. (-)-tetrahcycline Hydrochloride
85. Tetracycline Hydrochloride [jan]
86. Tetraciclina Cloridrato [italian]
87. Chlorowodorku Tetracykliny [polish]
88. (4s,4as,5as,6s,12as)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
89. Prestwick_434
90. Einecs 200-593-8
91. Bristacycline (tn)
92. Chlorhydrate De Tetracycline [french]
93. Tetracycline Hydrochloride [usp:jan]
94. Tetracycline Hydrochloride (internal Use)
95. Ai3-50120
96. Cas-64-75-5
97. Ncgc00016291-01
98. Tetracyclini Hydrochloridum
99. Ec 200-593-8
100. U-5965
101. Schembl34248
102. Spectrum1500566
103. Chembl454950
104. Dtxsid6021321
105. Nci-c55561;tetracycline Hcl
106. Tetracycline Hydrochloride, Powder
107. Hms1568k22
108. Hms1921c19
109. Pharmakon1600-01500566
110. Hy-b0474
111. Tox21_110355
112. Tox21_200516
113. Ccg-39267
114. Nsc757338
115. S2574
116. Akos015951263
117. Tox21_110355_1
118. Bcp9000227
119. Ks-1431
120. Nsc 757338
121. Tetracycline Hydrochloride (jp17/usp)
122. Tetracycline Hydrochloride [mi]
123. Ncgc00017323-08
124. Ncgc00180907-01
125. Ncgc00180907-02
126. Ncgc00258070-01
127. (4s,6s,12as,4as,5as)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,1 1-dioxo-4,5,6,12a,4a,5a-hexahydronaphthacene-2-carboxamide, Chloride
128. 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, Monohydrochloride, (4s,4as,5as,6s,12as)-
129. 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, Monohydrochloride, (4s-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-
130. Tetracycline Hydrochloride [mart.]
131. Tetracycline Hydrochloride [vandf]
132. Bcp0726000161
133. Tetracycline Hydrochloride [usp-rs]
134. Tetracycline Hydrochloride [who-dd]
135. Tetracycline Hydrochloride [who-ip]
136. Sw196293-4
137. D02122
138. D92606
139. Tetracycline Hydrochloride [green Book]
140. Tetracycline Hydrochloride [orange Book]
141. Tetracycline Hydrochloride [ep Monograph]
142. Apt T3x Component Tetracycline Tetracycline
143. Apt-t3x Component Tetracycline Tetracycline
144. Helidac Component Tetracycline Hydrochloride
145. Tetracycline Hydrochloride [usp Monograph]
146. Tetracyclini Hydrochloridum [who-ip Latin]
147. Sr-01000000212-4
148. Sr-05000001723-2
149. Q27286287
150. Tetracycline Hydrochloride 1000 Microg/ml In Ethanol
151. Tetracycline Hydrochloride Component Of Helidac
152. Tetracycline Tetracycline Component Of Apt T3x
153. Tetracycline Hydrochloride 100 Microg/ml In Acetonitrile
154. Tetracycline Hydrochloride, Meets Usp Testing Specifications
155. Tetracycline Hydrochloride, Vetranal(tm), Analytical Standard
156. Tetracycline Hydrochloride, >=95% (european Pharmacopoeia Hplc Assay)
157. Tetracycline Hydrochloride, British Pharmacopoeia (bp) Reference Standard
158. Tetracycline Hydrochloride, European Pharmacopoeia (ep) Reference Standard
159. Tetracycline Hydrochloride, Powder, Bioreagent, Suitable For Cell Culture
160. Tetracycline Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
161. Tetracycline Hydrochloride, United States Pharmacopeia (usp) Reference Standard
162. (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-3,4,4a,5,5a,6,12,12a-octahydrotetracene-2-carboxamide Hydrochloride
163. (4s,4as,5as,6s,12as)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamidehydrochloride
164. (4s,4as,5as,6s,12as)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Hydrochloride
165. (4s,4as,5as,6s,12as,z)-2-(amino(hydroxy)methylene)-4-(dimethylamino)-6,10,11,12a-tetrahydroxy-6-methyl-4a,5a,6,12a-tetrahydrotetracene-1,3,12(2h,4h,5h)-trione Hydrochloride
166. 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, Hydrochloride (1:1), (4s,4as,5as,6s,12as)-
167. 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, Monohydrochloride, (4s-(4.alpha.,4a.alpha.,5a.alpha.,6.beta.,12a.alpha.))-
168. 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, Monohydrochloride, (4s-(4alpha,4aalpha,5aalpha,6beta,12alpha))-
Molecular Weight | 480.9 g/mol |
---|---|
Molecular Formula | C22H25ClN2O8 |
Hydrogen Bond Donor Count | 7 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 2 |
Exact Mass | 480.1299435 g/mol |
Monoisotopic Mass | 480.1299435 g/mol |
Topological Polar Surface Area | 182 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 971 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Tetracycline hydrochloride |
Drug Label | Tetracycline is a yellow, odorless, crystalline powder. Tetracycline is stable in air but exposure to strong sunlight causes it to darken. Its potency is affected in solutions of pH below 2 and is rapidly destroyed by alkali hydroxide solutions. Tetr... |
Active Ingredient | Tetracycline hydrochloride |
Dosage Form | Capsule |
Route | Oral |
Strength | 250mg; 500mg; 100mg |
Market Status | Prescription |
Company | Watson Labs; Ivax Sub Teva Pharms; Impax Labs |
2 of 2 | |
---|---|
Drug Name | Tetracycline hydrochloride |
Drug Label | Tetracycline is a yellow, odorless, crystalline powder. Tetracycline is stable in air but exposure to strong sunlight causes it to darken. Its potency is affected in solutions of pH below 2 and is rapidly destroyed by alkali hydroxide solutions. Tetr... |
Active Ingredient | Tetracycline hydrochloride |
Dosage Form | Capsule |
Route | Oral |
Strength | 250mg; 500mg; 100mg |
Market Status | Prescription |
Company | Watson Labs; Ivax Sub Teva Pharms; Impax Labs |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Protein Synthesis Inhibitors
Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-01-24
Pay. Date : 2013-07-31
DMF Number : 13339
Submission : 1998-09-01
Status : Active
Type : II
Certificate Number : R1-CEP 2012-171 - Rev 01
Issue Date : 2022-11-10
Type : Chemical
Substance Number : 210
Status : Valid
NDC Package Code : 17158-0100
Start Marketing Date : 2017-12-17
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Century has been an API manufacturer for over 30 years & is the partner of choice for multipurpose custom manufacturing projects.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13718
Submission : 1998-09-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13659
Submission : 1998-09-01
Status : Active
Type : II
Certificate Number : R0-CEP 2006-128 - Rev 01
Issue Date : 2011-03-29
Type : Chemical
Substance Number : 210
Status : Expired
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13365
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13397
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13456
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11919
Submission : 1996-04-09
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13288
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-01-24
Pay. Date : 2013-07-31
DMF Number : 13339
Submission : 1998-09-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13288
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13397
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13365
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13377
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13373
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11919
Submission : 1996-04-09
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13348
Submission : 1998-09-01
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13394
Submission : 1998-09-01
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13357
Submission : 1998-09-01
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Certificate Number : R1-CEP 2012-171 - Rev 01
Status : Valid
Issue Date : 2022-11-10
Type : Chemical
Substance Number : 210
Tetracycline hydrochloride, Type 2
Certificate Number : CEP 2023-381 - Rev 00
Status : Valid
Issue Date : 2024-02-28
Type : Chemical
Substance Number : 210
Certificate Number : R0-CEP 2019-325 - Rev 00
Status : Valid
Issue Date : 2022-01-10
Type : Chemical
Substance Number : 210
Certificate Number : R1-CEP 2001-349 - Rev 04
Status : Valid
Issue Date : 2019-12-11
Type : Chemical
Substance Number : 210
Certificate Number : R0-CEP 2008-107 - Rev 00
Status : Expired
Issue Date : 2009-09-24
Type : Chemical
Substance Number : 210
Certificate Number : R0-CEP 2006-128 - Rev 01
Status : Expired
Issue Date : 2011-03-29
Type : Chemical
Substance Number : 210
About the Company : Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, manufacturing, & distributing high-quality APIs for the pharmaceutical indu...
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
Century has been an API manufacturer for over 30 years & is the partner of choice for multipurpose custom manufacturing projects.
About the Company : Century Pharmaceuticals, established in 1982, has 40 years of experience in manufacturing APIs. It has been supplying APIs produced in-house to several major pharma companies in In...
About the Company : Arudavis Labs is in the business of manufacturing and trading of Active Pharmaceutical Ingredients and Formulations. We have been serving the Pharmaceutical and Biotechnology Indus...
About the Company : We can help your company solve the payment problems during the trading from chinese factories. We supply you with OEM from china.We are professsionals with the competitive price an...
About the Company : Hebei Veyong Pharmaceutical Co., Ltd, was established in 2002 and located in Economic and Technological Development Zone in Shijiazhuang. It is a large veterinary enterprise with G...
About the Company : HENGDIAN GROUP was established in 1975, till now it has become a transnational,conglomerate group and been one of the largest private-owned enterprises in China. The Pharmaceutical...
About the Company : Established in 2002, Tecoland represents selected cGMP manufacturers with proven capabilities in organic synthesis, fermentation production as well as process and method developmen...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?